EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go?

Camille Kolenda iD, Julie Jourdan, Tiphaine Roussel-Gaillard, Mathieu Medina, Frédéric Laurent iD

Journal of Antimicrobial Chemotherapy · 04.11.2024 · 79 (11) · 2742-2749

DOI: 10.1093/jac/dkae325 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 13.09.2024. Verfasst von Camille Kolenda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service de bactériologie, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Bacteriophages, Phage Therapy. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phage therapy is a highly promising approach to address the challenge that is presented by the global burden of antimicrobial resistance. Given the natural specificity of phages, phage susceptibility testing (PST) is a prerequisite for successful personalized therapy, allowing the selection of active phages from large and diverse collections. However, the issue of an easy-to-use and standardized technique remains. In this review, we describe the principles, advantages and drawbacks of two routinely used PST techniques: plaque and growth kinetic assays. These are labour-intensive and time-consuming methods that require automation of one or more steps, including preparation of test panels, incubation, reading and analysis of results. In addition to automation, there is an urgent need to establish a reference method to enable efficient of PST techniques selection of therapeutic phages. We discuss knowledge gaps and parameters that need to be investigated to work towards this goal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriophagesPhage TherapyHumansViral Plaque AssayBacteria

Autor:innen und Institutionen

  • Service de bactériologie, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
  • Team StaPath, CIRI-Centre International de Recherche en Infectiologie, Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.

ORCID-Profile: Camille Kolenda, Frédéric Laurent

Zitieren

APA

Kolenda, C., Jourdan, J., Roussel-Gaillard, T., Medina, M., & Laurent, F. (2024). Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go?. Journal of Antimicrobial Chemotherapy, 79(11), 2742-2749. https://doi.org/10.1093/jac/dkae325

Vancouver

Kolenda C, Jourdan J, Roussel-Gaillard T, Medina M, Laurent F. Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go?. Journal of Antimicrobial Chemotherapy. 2024;79(11):2742-2749. doi:10.1093/jac/dkae325

BibTeX
@article{Kolenda2024,
  author = {Kolenda, Camille and Jourdan, Julie and Roussel-Gaillard, Tiphaine and Medina, Mathieu and Laurent, Frédéric},
  title = {Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go?},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  volume = {79},
  number = {11},
  pages = {2742--2749},
  doi = {10.1093/jac/dkae325}
}
Kostenlos starten →